Stacy Harper-Avilla, DEA Section Chief to Present at ACI's Summit on Controlled Substances
2nd Annual Summit on Controlled Substances Regulation, Litigation, and Enforcement | February 5-7, 2019 | Washington, DC
Julie Kurzrok, Legal Analyst and Conference Director at ACI, remarked, "we are most honored to hear from Ms. Harper-Avilla as she discusses the ins and outs of DEA's final Controlled Substances Quota Regulation. This unique opportunity provides stakeholders with the knowledge needed to perform assessments on internal policies and the ability to adjust business practices to minimize the impacts of the new quota requirements."
In addition to Mr. Harper-Avilla, the faculty includes current and former DEA and Government representatives, in-house executives, and leading law firm practitioners who will discuss the latest legal, enforcement, and regulatory developments affecting the opioid industry. Featured sessions include a roundtable of current and former state and federal enforcement officials discussing the latest enforcement initiatives, an in-depth analysis of the suspicious order monitoring and know your customer requirements, and insights into development of DEA's Suspicious Order Monitoring Guidance.
Full event information can be found at http://www.AmericanConference.com/